DEXIS announces the launch of the next-generation OP 3D. Built on OP 3D technology, the OP 3D LX introduces expanded 3D diagnostic capabilities with:
- Larger field of view (FOV) options now up to 15(H) x 20(D) cm
- Seamless integration with AI-enabled DTX StudioTM Clinic software
- Improved patient positioning
- Enhanced image clarity
- Cloud-based service connectivity
DEXIS will be demonstrating the new OP 3D LX at booth 956 during the Pacific Dental Conference in Vancouver, CA, on March 7-9, 2024.
“The OP 3D LX offers all the powerful features practices know and trust from our OP 3D line, with the addition of new innovations that provide expanded flexibility, improved workflow efficiencies, and enhanced diagnostic confidence,” says Lori Clements, Vice President, Commercial, North America at DEXIS. “With the addition of OP 3D LX in their practice, doctors will be able to enhance their diagnosis, planning, and treatment offerings for a wide range of patients and diagnostic needs.”
DEXIS has brought together some of the most recognized CBCT brands in the industry, including Instrumentarium, SOREDEXTM, Cranex, GendexTM and the well-known i-CATTM. Over the last 15 years, DEXIS has worked with distributors to install more than 35,000 CBCT units in dental practices and continues to serve their customers with the evolving OP 3D product line.
To learn more about the new DEXIS OP 3D LX, visit www.dexis.com.